Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06773351Phase 4Not yet recruiting
Phase 4, randomised trial of ciprofol (2 arms), sponsored by FengGao. Primary endpoints: Bispectral Index, Observer's Assessment of Alertness/Sedation Scale and 3 more. Planned start Feb 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06773351.